Grants for Public and State controlled institutions of higher education - Science and Technology

The FY24 PCRP Idea Development Award is intended to support new ideas that represent innovative approaches to prostate cancer research and have the potential to make an important contribution to the PCRP mission. The key components of this award mechanism are: Innovation: Research deemed innovative may represent a new paradigm, challenge current paradigms, look at existing problems from new perspectives, leverage unique study populations, or exhibit other highly creative qualities. Research that is an incremental advance upon published data is not considered innovative. Projects involving multidisciplinary and/or data science approaches are especially encouraged. Impact: Applications are required to address and provide a solution to one or more of the FY24 PCRP Overarching Challenges. The potential impact of the research, both short-term and long-term, in addressing the FY24 PCRP Overarching Challenge(s) should be clearly described. High-impact research will, if successful, significantly advance prostate cancer research and/or patient care. Preliminary Data: Due to this awards emphasis on innovation, the presentation of preliminary data relevant to prostate cancer and the proposed project is encouraged, but not required. Any unpublished, preliminary data provided should originate from the laboratory of the Principal Investigator (PI) or a member(s) of the research team. Regardless of whether preliminary data are included, applications should be based on a sound scientific rationale that is established through logical reasoning and/or critical review and analysis of the literature.New Investigator category: The FY24 PCRP Idea Development Award mechanism encourages research ideas from investigators in the early stages of their careers. The New Investigator category of this award mechanism is designed to allow applicant organizations to name PIs who are early in their faculty appointments or in the process of developing independent research careers. Applications submitted to the New Investigator category will be assessed using different review criteria for personnel (refer to Section II.E.1.a., Peer Review) and are required to include a collaborator (or collaborators) who has (have) experience in prostate cancer research, as demonstrated by a record of funding and publications. The application must describe the potential of the collaboration(s) to be successful and how the collaboration(s) will augment the PIs expertise to better address the research question. In addition, applicants are strongly encouraged to provide a letter of collaboration from the collaborator(s) describing the collaborator(s) involvement in the proposed work. All applicants for the New Investigator category must meet specific eligibility criteria described in Section II.C, Eligibility Information.Multidisciplinary projects are encouraged, and multi-institutional projects are allowed. Each proposed study must include a clearly stated plan for interactions among all team members and organizations involved. The plan must include communication, coordination of research progress and results, and data transfer. Additionally, multi-institutional applications must provide an intellectual property plan to resolve potential intellectual and material property issues and to remove institutional barriers that might interfere with achieving high levels of cooperation to ensure the successful completion of this award.Investigators are strongly encouraged to incorporate the following components into their study design, where appropriate, in order to maximize the potential impact of the proposed research project: authentication of proposed cell lines; statistical rigor of preclinical animal experiments; and incorporation of experiments to assess clinical relevance and translatability of findings. Studies utilizing data that are derived from large patient studies that include long-term health records, biospecimen repositories, and pre-existing research and apply state-of-the-art genomic and/or proteomic analysis, bioinformatics, and/or mathematical models to such data are also encouraged. Investigators are highly encouraged to provide a letter of support indicating access to and the availability of any resources required to support the study.A congressionally mandated Metastatic Cancer Task Force was formed with the purpose of identifying ways to help accelerate clinical and translational research aimed at extending the lives of advanced state and recurrent patients. As a member of the Metastatic Cancer Task Force, the CDMRP encourages applicants to review the recommendations (https://health.mil/Reference-Center/Congressional-Testimonies/2018/05/03/Metastatic-Cancer-Research) and submit research ideas to address these recommendations provided they are within the limitations of this funding opportunity and fit within the FY24 PCRP priorities.Innovative research involving nuclear medicine and related techniques to support early diagnosis, more-effective treatment, and improved health outcomes of active-duty Service Members and their Families is encouraged. Such research could improve diagnostic and targeted treatment capabilities through noninvasive techniques and may drive the development of precision imaging and advanced targeted therapies.Applications from investigators within the military services and applications involving multidisciplinary collaborations among academia, industry, the military services, the U.S. Department of Veterans Affairs (VA), and other federal government agencies are highly encouraged. These relationships can leverage knowledge, infrastructure, and access to unique clinical populations that the collaborators bring to the research effort, ultimately advancing research that is of significance to Service Members, Veterans, and/or their Families. If the proposed research relies on access to unique resources or databases, the application must describe the access at the time of submission and include a plan for maintaining access as needed throughout the proposed research.All projects should adhere to a core set of standards for rigorous study design and reporting to maximize the reproducibility and translational potential of clinical and preclinical research. The standards are described in SC Landis et al., 2012, A call for transparent reporting to optimize the predictive value of preclinical research, Nature 490:187-191 https://www.nature.com/nature/ journal/v490/n7419/full/nature11556.html). While these standards are written for preclinical studies, the basic principles of randomization, blinding, sample-size estimation, and data handling derive from well-established best practices in clinical studies.Clinical trials are not allowed. A clinical trial is defined in the Code of Federal Regulations, Title 45, Part 46.102 (45 CFR 46.102) as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include a placebo or another control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes.Studies that do not seek to measure safety, effectiveness, and/or efficacy outcome(s) of an intervention are not considered clinical trials.For the purposes of this funding opportunity, research that meets the definition of a clinical trial is distinct from clinical research. Clinical research encompasses research with human data, human specimens, and/or interaction with human subjects. Clinical research is observational in nature and includes:(1) Research conducted with human subjects and/or material of human origin such as data, specimens, and cognitive phenomena for which an investigator (or co-investigator) does not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention. Research meeting this definition may include but is not limited to: (a) mechanisms of human disease, (b) diagnostic or detection studies (e.g., biomarker or imaging), (c) health disparity studies, and (d) development of new technologies.(2) Epidemiologic and behavioral studies that do not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention.(3) Outcomes research and health services research that do not fit under the definition of clinical trial.Excluded from the definition of clinical research are in vitro studies that utilize human data or specimens that cannot be linked to a living individual and meet the requirements for exemption under 46.104(d)(4) of the Common Rule.The funding instrument for awards made under the program announcement will be grants (31 USC 6304).The anticipated direct costs budgeted for the entire period of performance for an FY24 PCRP Idea Development Award should not exceed $1.2M. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.Awards supported with FY24 funds will be made no later than September 30, 2025.The CDMRP expects to allot approximately $53.76M to fund approximately 28 Idea Development Award applications. Funding of applications received is contingent upon the availability of federal funds for this program, the number of applications received, the quality and merit of the applications as evaluated by peer and programmatic review, and the requirements of the government. Funds to be obligated on any award resulting from this funding opportunity will be available for use for a limited time period based on the fiscal year of the funds. It is anticipated that awards made from this FY24 funding opportunity will be funded with FY24 funds, which will expire for use on September 30, 2030.

This funding opportunity supports innovative basic research in behavioral and social sciences to improve the Army's ability to develop and retain professional Soldiers, targeting universities, nonprofits, and commercial organizations.

This funding opportunity supports innovative scientific research and technology development relevant to maritime applications, inviting proposals from academia, industry, and research institutions, including Historically Black Colleges and Universities and Minority Institutions.

Humanities Montana Research Fellowship supports projects with a central focus in the humanities, a clearly defined theme, and involvement of professional humanists. Projects must include a public program, publicity, and evaluation plans where appropriate. There is a 1:1 cost-share requirement and applications involving Native American communities or cultures must demonstrate their involvement or address why they are not involved. Humanities Montana cannot fund projects focusing on personal concerns, non-public meetings, construction or operating expenses of existing organizations, lobbying or direct social action, one-sided treatment of an issue, fundraising for profit-making groups, alcoholic beverages or entertainment costs, and candidates running for political office.

With this solicitation, NIJ seeks proposals for rigorous research and evaluation projects that inform policy and practice in the field of youth justice and delinquency prevention. Specifically, this solicitation seeks proposals for studies that advance knowledge and understanding in the following two categories: 1. Youth Justice Reinvestment Studies which evaluate the effectiveness, including cost-effectiveness, of youth justice system reforms and subsequent reinvestments into programs that serve youth in their communities. 2. Prevention and Intervention Program Effectiveness Studies which evaluate the effectiveness of school and community-based prevention and intervention programs.

This funding opportunity supports advanced training for researchers, particularly those from underrepresented groups, to improve employment outcomes for individuals with disabilities through rigorous, multidisciplinary rehabilitation research.

The Washington State Department of Commerce is launching an accelerated cohort of its Innovation Cluster Accelerator Program (ICAP 2.5). This initiative is an economic development strategy designed to bolster industry ecosystems and stimulate economic growth across the state. The program aims to assist organizations in expanding cluster operations, fostering innovation in key sectors, and drawing in talent and capital. While not explicitly detailed as a "foundation mission alignment," the program's objectives clearly align with broader state economic development goals, serving as a strategic framework to enhance Washington's competitive advantage in global industry sectors. The primary beneficiaries of this grant are industry-led consortia/clusters that demonstrate a commitment to building successful clusters. These consortia must include academic membership, evidenced by a letter of commitment from a major university or community college within Washington State. Furthermore, eligible clusters must demonstrate over $500,000 in investment, which can include prospective federal funding. The program prioritizes clusters that are truly industry-led, ensuring that funding supports initiatives with strong private sector engagement and a clear path to market-driven innovation and growth. The program's priorities and focus areas are multifaceted, designed to strengthen Washington's economic landscape. Key goals include establishing Washington as a global leader in critical industry sectors, supporting technology transfer and commercialization, accelerating the growth of new start-ups and scale-ups, and expanding existing businesses. A significant focus is placed on creating high-value jobs across Washington, increasing export opportunities, and promoting diversity, equity, and inclusion in both business ownership and the workforce. These priorities underscore a comprehensive approach to economic development that values innovation, job creation, and equitable growth. Expected outcomes and measurable results are integral to the ICAP 2.5. COMMERCE intends to award no more than 10 applications, with individual grants ranging from $50,000 to $150,000. The project period is tentatively set to commence around September 1, 2024, and conclude by December 31, 2024, indicating a short, high-impact performance window. The success of the program will be measured by its ability to drive cluster operations, innovation in key sectors, and the attraction of talent and capital, all contributing to the overarching goal of accelerating economic development and strengthening industry ecosystems. While a formal "theory of change" is not explicitly stated, the program's design implicitly operates on the theory that targeted investment in industry-led consortia will foster innovation, create high-value jobs, and ultimately establish Washington as a leader in key industry sectors, thereby increasing economic prosperity and global competitiveness.

This program provides funding for educational and research opportunities in Earth Sciences, targeting undergraduate students, teachers, postdoctoral researchers, and early-career faculty to promote broader participation in the field.

This grant provides funding for researchers studying ancient sediments and fossils to better understand the Earth's history, environmental changes, and the evolution of life before the Holocene epoch.

The Federal and State Technology (FAST) Partnership Program provides funding to organizations to execute state/regional programs that increase the number of SBIR/STTR proposals leading to an increase in the number of SBIR/STTR awards from women, socially/economically disadvantaged individuals, and small businesses in underrepresented areas - typically rural states.

This funding opportunity supports organizations that partner with startups to advance and scale innovative clean energy technologies in Massachusetts, helping them navigate challenges to achieve commercial success.

The "NSF Research: Centers for Chemical Innovation" grant supports research centers focused on major chemical research challenges, aiming to produce transformative research and innovation, with a two-phase program that provides resources for development before moving to the next phase, and is open to projects in fields like Advanced Manufacturing, Artificial Intelligence, and Clean Energy.

This funding opportunity supports collaborative research between Israeli and American scientists to advance sustainable aquaculture and desert farming practices, enhancing food security and ecological conservation.

This funding opportunity provides financial support for U.S. and Japanese organizations, educational institutions, and individuals to develop projects that strengthen U.S.-Japan relations through cultural, educational, and strategic initiatives.

Supports applications that propose innovative cancer clinical studies in adults or children and adolescents that are hypothesis driven and involve patients enrolled prospectively on a clinical trial. Areas of interest include clinical studies of new or repurposed drugs, hormonal therapies, immune therapies, surgery, radiation therapy, stem cell transplantation, combinations of interventions, or therapeutic devices. Clinical trial must be planned to begin when contract is awarded.

This funding opportunity provides financial support to organizations in New Jersey to enhance digital literacy and access to training for low-income adults receiving public assistance benefits.

This funding opportunity provides financial support for research and evaluation projects that explore the impact of forensic science on the criminal justice system, targeting a wide range of eligible applicants including government agencies, educational institutions, and nonprofit organizations.

The Advancing Informal STEM Learning (AISL) Program is committed to funding research and practice, with continued focus on investigating a range of informal STEM learning (ISL) experiences and environments that make lifelong learning a reality. This Program seeks proposals that center equity and belonging, and further the well-being of individuals and communities who have historically been and continue to be excluded, underserved, or underrepresented, due to gender, race, ethnicity, sexual orientation, disability status, neurodiversity, geographic location, and economic status, among others, as well as their intersections. The current solicitation encourages proposals from institutions and organizations that serve public audiences, and specifically focus on public engagement with and understanding of STEM, including community STEM; public participation in scientific research (PPSR); science communication; intergenerational STEM engagement; and STEM media. Projects funded by AISL should contribute to research and practice that further illuminates informal STEM learnings role in equity and belonging in STEM; personal and educational success in STEM; advancing public engagement in scientific discovery; fostering interest in STEM careers; creating and enhancing the theoretical and empirical foundations for effective informal STEM learning; improving community vibrancy; and/or enhancing science communication and the publics engagement in and understanding of STEM and STEM processes. The AISL Program funds five types of projects: (1) Synthesis; (2) Conference; (3) Partnership Development and Planning; (4) Integrating Research and Practice; and (5) Research in Support of Wide-reaching Public Engagement with STEM. NOTE: Activities primarily focused on formal educational systems or outcomes are outside the scope of work supported by this program. AISL does not fund formal elementary, middle, or high school, or undergraduate or graduate education, whether in-person or online. Similarly, AISL does not fund formal workforce training (e.g., professional certifications and degree-earning programs) that is not aimed directly at informal STEM learning professionals.

This funding opportunity provides financial support to nonprofit organizations and educational institutions in the U.S. and Kazakhstan to strengthen ties through sports and digital skills development, particularly for young professionals outside major cities.

This funding opportunity supports U.S.-based healthcare organizations working with maternal care professionals to create culturally relevant educational materials and tools that improve access to maternal immunization resources, particularly in underserved communities.